EGFR and prostate carcinoma: For example, excessive ROS can inhibit Epidermal Growth Factor Receptor (EGFR)-mediated Phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway and block the proliferation of androgen-independent prostate cancer cells (96).